It is a successful viral strategy to steal a host protein and evolve it into viral RBDs with novel protein receptor specificities or altered sugar receptor specificities. For example, MHV and BCoV S1-NTDs have the structural fold as human galectins, but they recognize a novel protein receptor and a different sugar receptor, respectively.
